Equities

Morpho Inc

3653:TYO

Morpho Inc

Actions
TechnologyTechnology
  • Price (JPY)1,825.00
  • Today's Change-14.00 / -0.76%
  • Shares traded76.10k
  • 1 Year change+71.20%
  • Beta1.2976
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Oct 31 2023202320222021
ASSETS
Cash And Short Term Investments2,7123,0603,392
Total Receivables, Net517485419
Total Inventory341012
Prepaid expenses611840
Other current assets, total6.3820215
Total current assets3,3303,5934,077
Property, plant & equipment, net5226126
Goodwill, net------
Intangibles, net13045
Long term investments267193166
Note receivable - long term626868
Other long term assets(21)(24)68
Total assets3,7073,8604,550
LIABILITIES
Accounts payable95127109
Accrued expenses572418
Notes payable/short-term debt000
Current portion long-term debt/capital leases141313
Other current liabilities, total343289222
Total current liabilities509453362
Total long term debt2208.95
Total debt361322
Deferred income tax245.20--
Minority interest------
Other liabilities, total3.532.8229
Total liabilities559461400
SHAREHOLDERS EQUITY
Common stock1,7841,7841,784
Additional paid-in capital1,7331,7331,733
Retained earnings (accumulated deficit)(111)189847
Treasury stock - common(371)(371)(210)
Unrealized gain (loss)5412--
Other equity, total6053(3.94)
Total equity3,1493,3994,150
Total liabilities & shareholders' equity3,7073,8604,550
Total common shares outstanding5.135.135.26
Treasury shares - common primary issue0.280.280.16
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.